A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects
Clinical trial NCT04651036 · UNKNOWN
Trial details
- NCT number
- NCT04651036
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-06
- Primary completion
- 2021-11-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.